HENGRUI PHARMA_Providing professional financial news and data related to HENGRUI PHARMA, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

HENGRUI PHARMA(01276.HK): Receives Clinical Trial Approval for SHR-1049 Injection, Targeting Advanced Solid Tumors

Tags：

HENGRUI PHARMA 01276.HK

2026-01-26

ETF
Global Semiconductor Sales to Top $1 Trillion for First Time in 2026, Samsung Bloomberg Global Semiconductor Etf (03132.HK) Surges Over 2%
ETF
Hang Seng Tech Index Drops Nearly 3%, Internet Technology Stocks Broadly Decline, iShares Hang Seng Tech ETF (03067.HK) Falls Over 2.5%
ETF
Betting on SpaceX! Korean Brokerage Stocks Surge 200%, Xtrackers MSCI Korea UCITS ETF (02848.HK) Jumps Over 4%
ETF
ChinaAMC CNI Aerospace Industry ETF(159227) Rises 1.58% Intraday,Institutions See Promising Prospects for Commercial Aerospace in Construction Phase
ETF
ChinaAMC Guozheng Semiconductor Chip ETF(159995) Rises 0.78% Intraday,AI Chip Layout Coupled with Sustained Policy Benefits Boosts the Sector
ETF
Institution: The Industry Enters a Dual-Driven Era at the Start of the 15th Five-Year Plan,GF CSI Military Industry ETF(512680) Rises 0.73% Intraday
ETF
Improved Spring Festival Offtake Lifts Market Sentiment,Penghua CSI Alcoholic Drink Index ETF(512690) Rises 0.75% Intraday
ETF
China Merchants CSI Semiconductor Industry ETF(561980) Rises 1.79% Intraday,Policy Empowerment Fuels Localization Wave
ETF
Liquor Sales Heat Up Ahead of Spring Festival! E Fund CSI Liquor Index ETF (03189.HK) Rises Over 1% Against Market Trend
Finance
CASA HOLDINGS LIMITED Announces Proposed Acquisition of 80% Equity in POLYBUILDING (S) PTE. LTD. for S$13.2 Million

Scan QR Code

Download App